Krystal Biotech Stock
Krystal Biotech Stock
The Krystal Biotech stock is trending slightly upwards today, with an increase of €1.00 (0.610%) compared to yesterday's price.
With 14 Buy predictions and not the single Sell prediction the community is currently very high on Krystal Biotech.
At the moment Krystal Biotech has reached the predicted target price of 166 €, with a current price of 165.0 €.
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Krystal Biotech stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of Krystal Biotech in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
?
S********** s********
Cons
?
M***** P*******
?
B****
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Krystal Biotech vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Krystal Biotech | 0.610% | 6.494% | 4.459% | 121.622% | 41.379% | - | - |
Salarius Pharmaceuticals Inc. | 1.470% | -21.538% | -20.000% | -76.920% | -26.486% | -98.684% | -99.992% |
Ardelyx Inc. | 0.000% | -3.641% | -22.870% | 71.742% | 19.031% | 28.024% | - |
Evolus Inc | 0.770% | 1.563% | -2.985% | 66.667% | 39.037% | 31.287% | - |
Comments
Krystal Biotech, Inc. (NASDAQ: KRYS) had its price target raised by analysts at Citigroup Inc. from $160.00 to $195.00. They now have a "buy" rating on the stock.
Show more
Ratings data for KRYS provided by MarketBeat
Krystal Biotech, Inc. (NASDAQ: KRYS) had its price target raised by analysts at Guggenheim from $130.00 to $175.00. They now have a "buy" rating on the stock.
Show more
Ratings data for KRYS provided by MarketBeat
Krystal Biotech, Inc. (NASDAQ: KRYS) had its "outperform" rating re-affirmed by analysts at William Blair.
Show more
Ratings data for KRYS provided by MarketBeat